vs
Side-by-side financial comparison of DESTINATION XL GROUP, INC. (DXLG) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
DESTINATION XL GROUP, INC. is the larger business by last-quarter revenue ($101.9M vs $70.6M, roughly 1.4× Viridian Therapeutics, Inc.\DE). DESTINATION XL GROUP, INC. runs the higher net margin — -4.0% vs -49.0%, a 45.0% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -5.2%). DESTINATION XL GROUP, INC. produced more free cash flow last quarter ($-6.0M vs $-84.7M).
Destination XL Group, Inc. (DXLG) is a leading retailer of Men's Big and Tall apparel with 290 retail and outlet store locations throughout the United States operated under the business subsidiaries DXL and Casual Male XL. The company also operates an e-commerce website (dxl.com) and an Android and iOS mobile app serving customers in the United States, Canada, The United Kingdom, Greater China and other global markets. The company is headquartered in Canton, Massachusetts, and is listed on th...
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
DXLG vs VRDN — Head-to-Head
Income Statement — Q3 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $101.9M | $70.6M |
| Net Profit | $-4.1M | $-34.6M |
| Gross Margin | 42.7% | — |
| Operating Margin | -5.6% | -56.7% |
| Net Margin | -4.0% | -49.0% |
| Revenue YoY | -5.2% | 81958.1% |
| Net Profit YoY | -128.3% | 54.9% |
| EPS (diluted) | $-0.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $101.9M | — | ||
| Q3 25 | $115.5M | $70.6M | ||
| Q2 25 | $105.5M | — | ||
| Q1 25 | $119.2M | — | ||
| Q4 24 | $107.5M | — | ||
| Q3 24 | $124.8M | — | ||
| Q2 24 | $115.5M | — | ||
| Q1 24 | $137.1M | — |
| Q4 25 | $-4.1M | — | ||
| Q3 25 | $-265.0K | $-34.6M | ||
| Q2 25 | $-1.9M | — | ||
| Q1 25 | $-1.3M | — | ||
| Q4 24 | $-1.8M | — | ||
| Q3 24 | $2.4M | — | ||
| Q2 24 | $3.8M | — | ||
| Q1 24 | $5.2M | — |
| Q4 25 | 42.7% | — | ||
| Q3 25 | 45.2% | — | ||
| Q2 25 | 45.1% | — | ||
| Q1 25 | 44.4% | — | ||
| Q4 24 | 45.1% | — | ||
| Q3 24 | 48.2% | — | ||
| Q2 24 | 48.2% | — | ||
| Q1 24 | 47.0% | — |
| Q4 25 | -5.6% | — | ||
| Q3 25 | 0.6% | -56.7% | ||
| Q2 25 | -3.3% | — | ||
| Q1 25 | -1.5% | — | ||
| Q4 24 | -2.4% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 5.9% | — |
| Q4 25 | -4.0% | — | ||
| Q3 25 | -0.2% | -49.0% | ||
| Q2 25 | -1.8% | — | ||
| Q1 25 | -1.1% | — | ||
| Q4 24 | -1.7% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 3.8% | — |
| Q4 25 | $-0.08 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $-0.04 | — | ||
| Q1 25 | $-0.02 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $0.04 | — | ||
| Q2 24 | $0.06 | — | ||
| Q1 24 | $0.08 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.0M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $137.2M | $503.0M |
| Total Assets | $401.5M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.0M | — | ||
| Q3 25 | $33.5M | $490.9M | ||
| Q2 25 | $29.1M | — | ||
| Q1 25 | $48.4M | — | ||
| Q4 24 | $43.0M | — | ||
| Q3 24 | $63.2M | — | ||
| Q2 24 | $53.2M | — | ||
| Q1 24 | $60.0M | — |
| Q4 25 | $137.2M | — | ||
| Q3 25 | $140.9M | $503.0M | ||
| Q2 25 | $140.7M | — | ||
| Q1 25 | $141.2M | — | ||
| Q4 24 | $145.5M | — | ||
| Q3 24 | $157.0M | — | ||
| Q2 24 | $153.6M | — | ||
| Q1 24 | $149.0M | — |
| Q4 25 | $401.5M | — | ||
| Q3 25 | $408.8M | $577.1M | ||
| Q2 25 | $380.1M | — | ||
| Q1 25 | $381.0M | — | ||
| Q4 24 | $381.3M | — | ||
| Q3 24 | $383.8M | — | ||
| Q2 24 | $376.6M | — | ||
| Q1 24 | $357.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $-84.6M |
| Free Cash FlowOCF − Capex | $-6.0M | $-84.7M |
| FCF MarginFCF / Revenue | -5.9% | -120.1% |
| Capex IntensityCapex / Revenue | 4.8% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-11.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.1M | — | ||
| Q3 25 | $9.9M | $-84.6M | ||
| Q2 25 | $-12.0M | — | ||
| Q1 25 | $17.1M | — | ||
| Q4 24 | $-3.5M | — | ||
| Q3 24 | $17.1M | — | ||
| Q2 24 | $-1.1M | — | ||
| Q1 24 | $16.5M | — |
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $4.6M | $-84.7M | ||
| Q2 25 | $-18.8M | — | ||
| Q1 25 | $8.8M | — | ||
| Q4 24 | $-10.1M | — | ||
| Q3 24 | $10.2M | — | ||
| Q2 24 | $-7.0M | — | ||
| Q1 24 | $9.5M | — |
| Q4 25 | -5.9% | — | ||
| Q3 25 | 3.9% | -120.1% | ||
| Q2 25 | -17.8% | — | ||
| Q1 25 | 7.4% | — | ||
| Q4 24 | -9.4% | — | ||
| Q3 24 | 8.2% | — | ||
| Q2 24 | -6.1% | — | ||
| Q1 24 | 6.9% | — |
| Q4 25 | 4.8% | — | ||
| Q3 25 | 4.6% | 0.2% | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 6.2% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 5.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.17× | — | ||
| Q2 24 | -0.30× | — | ||
| Q1 24 | 3.15× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXLG
| Sales Channel Through Intermediary | $74.5M | 73% |
| Sales Channel Directly To Consumer | $27.3M | 27% |
VRDN
Segment breakdown not available.
